Saturday, 23 March 2019
Latest news
Main » Chemical Bank Purchases 2000 Shares of Eastman Chemical (EMN)

Chemical Bank Purchases 2000 Shares of Eastman Chemical (EMN)

16 April 2018

Therefore 62% are positive. Sarepta Therapeutics had 113 analyst reports since August 5, 2015 according to SRatingsIntel. RBC Capital Markets has "Outperform" rating and $86.0 target. Needham maintained the stock with "Buy" rating in Thursday, October 26 report. Cowen & Co maintained the stock with "Buy" rating in Thursday, July 13 report. On Friday, February 2 the rating was maintained by SunTrust with "Hold". The ex-dividend date of this dividend is Monday, March 13th. "Buy" rating has 6, "Sell" are 0, while 3 are "Hold". The firm has "Neutral" rating by Citigroup given on Wednesday, September 7. On Friday, October 27 the rating was maintained by UBS with "Buy". In Monday, January 8 report KeyBanc Capital Markets maintained it with "Buy" rating and $118.0 target. See Sarepta Therapeutics, Inc. P/E is a popular valuation ratio of a company's current share price compared to its per-share earnings (trailing twelve months). If reported the P/E will be 12.55 with $299.80M profit. During the same quarter in the previous year, the firm earned $1.51 EPS. The stock decreased 0.72% or $0.77 during the last trading session, reaching $105.44. Based on a recent trade, the shares are -6.23% away from the 52-week high and 38.54% from the 52-week low. EMN outperformed the S&P 500 by 23.19%.

Investors sentiment decreased to 1 in Q4 2017. Its down 1.66, from 2.88 in 2017Q3. Following the completion of the transaction, the chief accounting officer now owns 19,781 shares in the company, valued at $1,994,320.42. 45 funds opened positions while 70 raised stakes. Employees Retirement Association Of Colorado holds 0.02% or 28,494 shares.

Oak Ridge Investments Llc decreased Incyte Corp Com (INCY) stake by 40.24% reported in 2017Q4 SEC filing. Bluecrest Mgmt Limited accumulated 31,929 shares. Investors of record on Thursday, March 15th will be given a dividend of $0.56 per share. 13,560 are owned by Natixis. Livforsakringsbolaget Skandia Omsesidigt holds 0.02% of its portfolio in Incyte Corporation (NASDAQ:INCY) for 2,700 shares. Aviva Public Limited stated it has 80,552 shares. Peak6 Invests LP invested 0% in Owens & Minor, Inc.

A total of 9 analysts rate Eastman Chemical (NYSE:EMN) as follows: 6 "Buy", 3 "Hold" and 0 "Sell".

Sarepta Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery and development of RNA therapeutics for the treatment of rare neuromuscular diseases. For the past 5 years, The Company's EPS growth has been almost 19.60%. Ameriprise Financial Inc. now owns 2,930,981 shares of the basic materials company's stock valued at $265,234,000 after acquiring an additional 223,382 shares in the last quarter. About 1.99 million shares traded. Alibaba Group Holding Limited (NYSE:BABA) has risen 68.29% since April 15, 2017 and is uptrending.

Since October 31, 2017, it had 0 buys, and 10 insider sales for $9.32 million activity. Over the last ninety days, insiders have sold 56,318 shares of company stock valued at $4,449,812. Also, SVP David A. Golden sold 8,600 shares of the company's stock in a transaction that occurred on Monday, April 2nd. King Scott V. had sold 9,883 shares worth $996,437 on Thursday, March 1. The insider ESPELAND CURTIS E sold $4.70 million. On Friday, February 9 Shares for $315,875 were sold by BOLDEA LUCIAN.

The Return on Invested Capital (aka ROIC) for Solid State plc (AIM:SOLI) is 0.193099. Its down 0.01, from 1.18 in 2017Q3.

NA increased its position in Eastman Chemical (NYSE:EMN) by 2.0% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). 74 funds took stakes and 182 increased stakes. The basic materials company reported $1.62 earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of $1.06 by $0.56. The RSI for Eastman Chemical Company (NYSE:EMN) now stands at 53.41. Amundi Pioneer Asset owns 279,789 shares. 1,768 were reported by Whittier. Hedge funds and other institutional investors own 85.48% of the company's stock. 58,640 are held by Hendley &. Moreover, Ifrah Svcs has 0.17% invested in Eastman Chemical Company (NYSE:EMN) for 4,984 shs. Dearborn Partners Limited Liability Corp holds 3,119 shares or 0.02% of its portfolio.

Eastman Chemical (NYSE:EMN) last issued its quarterly earnings results on Thursday, February 1st. Stephens Ar, a Arkansas-based fund reported 18,829 shs. Walter Keenan Consulting Mi Adv stated it has 3,900 shares. Eastman Chemical Company (NYSE:EMN)'s Williams %R presently stands at -23.59. As such, analysts can estimate Eastman Chemical Company's growth for next year as 8.19%. First Citizens Bancorporation And Tru holds 20,129 shares or 0.25% of its portfolio. Bronson Point Management Llc who had been investing in Eastman Chem Co for a number of months, seems to be bullish on the $15.05B market cap company. The company's Additives & Functional Products segment offers specialty coalescents, specialty and commodity solvents, paint additives, and specialty polymers; hydrocarbon and rosin resins; insoluble sulfur and antidegradant rubber additives; performance resins and amine derivative-based building blocks; heat transfer and aviation fluids; formic acid-based solutions; and metam-based soil fumigants, thiram and ziram based fungicides, and plant growth regulators. The Company's products are used in coatings, tires, consumables, building and construction, animal nutrition, care chemical, crop protection, and energy markets.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.